Article info

Download PDFPDF

Clinical features and outcomes of COVID-19 in patients with rheumatic diseases treated with biological and synthetic targeted therapies

Authors

  1. Correspondence to Dr Jose M Alvaro-Gracia, Rheumatology, Hospital General Universitario Gregorio Marañón, 28007 Madrid, Spain; jalvarogracia{at}gmail.com
View Full Text

Citation

Sanchez-Piedra C, Diaz-Torne C, Manero J On behalf of the BIOBADASER study group, et al
Clinical features and outcomes of COVID-19 in patients with rheumatic diseases treated with biological and synthetic targeted therapies

Publication history

  • Received May 12, 2020
  • Revised May 21, 2020
  • Accepted May 22, 2020
  • First published June 5, 2020.
Online issue publication 
June 14, 2020

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.